Journal of Tissue Engineering and Regenerative Medicine

Papers
(The median citation count of Journal of Tissue Engineering and Regenerative Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Corrigendum43
Evolution of functional tissue engineering for tendon and ligament repair27
Application of Tendon‐Derived Matrix and Carbodiimide Crosslinking Matures the Engineered Tendon‐Like Proteome on Meltblown Scaffolds24
22
The intra‐articular injection of adipose‐derived stem cells decreases pain and reduces inflammation in knee osteoarthritis, with or without the addition of platelet‐rich plasma also improves functiona20
Platelet‐rich plasma in the treatment of scars, to suggest or not to suggest? A systematic review and meta‐analysis20
Combination Therapy of Losartan and Fisetin Reduces Senescence and Enhances Osteogenesis in Human Bone Marrow–Derived Mesenchymal Stem Cells20
Harnessing the Regenerative Potential of Fetal Mesenchymal Stem Cells and Endothelial Colony‐Forming Cells in the Biofabrication of Tissue‐Engineered Vascular Grafts (TEVGs)18
Applied Electric Fields Polarize Initiation and Growth of Endothelial Sprouts18
Matricellular protein Tenascin‐C enhances mesenchymal stem cell angiogenic and wound healing efficacy under ischemic conditions18
Three‐dimensional wet electrospun scaffold system for the differentiation of adipose‐derived mesenchymal stem cells to islet‐like clusters16
16
Application of amniotic membranes in reconstructive surgery of internal organs—A systematic review and meta‐analysis15
Cartilage‐penetrating hyaluronic acid hydrogel preserves tissue content and reduces chondrocyte catabolism15
Amniotic Membrane and Mesenchymal Stem Cell Coalescence for Islet Transplantation in Experimental Diabetes in Rats14
The Chorioallantoic Membrane as a Platform for Developing Vascularized Cell Macroencapsulation Devices13
A concise review of the orofacial mesenchymal stromal cells as a novel therapy for neurological diseases and injuries13
Stem cell‐based strategies for skeletal muscle tissue engineering13
GMP‐grade microcarrier and automated closed industrial scale cell production platform for culture of MSCs12
Bilateral Crosslinking with Glutaraldehyde and 1-Ethyl-3-(3-Dimethylaminopropyl) Carbodiimide: An Optimization Strategy for the Application of Decellularized Human Amniotic Membrane in Tissue Engineer11
Modeling the human heart ex vivo—current possibilities and strive for future applications11
RETRACTION: “Mechanical stretch promotes antioxidant responses and cardiomyogenic differentiation in P19 cells”10
Chromatin Condensation Delays Senescence in Human Mesenchymal Stem Cells by Safeguarding Nuclear Damages during In Vitro Expansion10
10
Examination of epigenetic inhibitor zebularine in treatment of skin wounds in healthy and diabetic mice10
Issue Information8
Issue Information8
7
Polycaprolactone Fiber and Laminin and Collagen IV Protein Incorporation in Implants Enhances Wound Healing in a Novel Mouse Skin Splint Model7
Effective decellularization of human skin tissue for regenerative medicine by supercritical carbon dioxide technique7
Issue Information7
Effect of amniotic membrane and platelet‐rich fibrin membrane on bone healing post endodontic surgery: An ultrasonographic, randomized controlled study7
Corrigendum to “Plant‐Origin Compounds and Materials for Advancing Bone Tissue Engineering and 3D Bioprinting: Traditional Medicine Aspects and Current Perspectives”6
Biomaterials directed activation of a cryostable therapeutic secretome in induced pluripotent stem cell derived mesenchymal stromal cells6
Challenges and Advances in Peripheral Nerve Tissue Engineering Critical Factors Affecting Nerve Regeneration6
FlexMetric bone marrow aspirator yields laboratory and clinically improved results from mesenchymal stem and progenitor cells without centrifugation6
RETRACTION: Design and development of thyroxine/heparin releasing affordable cotton dressings to treat chronic wounds6
Recent scaffold‐based tissue engineering approaches in premature ovarian failure treatment6
Controlled Release of Mesenchymal Stem Cell-Conditioned Media from a Microsphere/Gel-Based Drug Delivery System for Wound Healing of Tympanic Membrane Perforations6
Viewing Decellularized Amniotic Membrane Through the Lens of Coupled Scaffolding and Drug Delivery Systems in Regenerative Medicine5
Accelerated vascularization of a novel collagen hydrogel dermal template5
Cover Image4
4
Genetically Engineered Macrophages Derived from iPSCs for Self-Regulating Delivery of Anti-Inflammatory Biologic Drugs4
Issue Information3
Engineered Decellularized Tendon Matrix Putty Preserves Native Tendon Bioactivity to Promote Cell Proliferation and Enthesis Repair3
Issue Information3
Pirfenidone Attenuates Fibrosis and Neovascularization in 3D Spheroid‐Laden Hydrogel Culture3
Cranial Defect Reconstruction With Custom 3D‐Printed Hydroxyapatite Scaffolds Augmented With rhBMP‐2 or Dipyridamole in a Nonhuman Primate Model3
3
Nanofibrous polytetrafluoroethylene/poly(ε‐caprolactone) membrane with hierarchical structures for vascular patch3
Femtosecond Laser Engraving Promotes the Repopulation of Decellularized Human Articular Cartilage2
Histologic characterization of orbicularis oris muscle with a new acellular dermal matrix grafts in a rabbit model2
Development of a biomimetic bioreactor for regenerative endodontics research2
Recent advances in gene therapy for bone tissue engineering2
2
Long‐term passages of human clonal mesenchymal stromal cells can alleviate the disease in the rat model of collagen‐induced arthritis resembling early passages of different heterogeneous cells2
Optimisation and Validation of an Induced Membrane Technique Model to Assess Bone Regeneration in Rats2
SphK1 Suppresses Human Dental Pulp Stem Cell Apoptosis by Promoting Glycolysis Under Simulated Microgravity2
3D‐Printed Triply Periodic Minimal Surface Ceramic Scaffold Loaded With Bone Morphogenetic Protein‐2 and Zoledronic for Cranium Defect Repairment2
0.055655956268311